Skip to content

Research

All Research Featured Research

Read: Remote Blood Collection Shows Promise for Alzheimer’s Research

News

Remote Blood Collection Shows Promise for Alzheimer’s Research

June 10, 2024

Read: A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development

Journal Article

A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development

May 22, 2024

Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD

Read: Reporting and Representation of Participant Demographic Information in Completed Alzheimer’s Disease Clinical Trials

Journal Article

Reporting and Representation of Participant Demographic Information in Completed Alzheimer’s Disease Clinical Trials

May 15, 2024

Featured Experts: Mireille Jacobson, PhD

Read: Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care

Perspective

Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care

April 9, 2024

Featured Experts: Jakub Hlávka, PhD, Eugene Lin, MD, MS

Read: Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?

Evidence Base

Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?

December 15, 2023

Featured Experts: Alison Sexton Ward, PhD, Desi Peneva, MS

Read: USC Receives Award to Improve Diversity and Efficiency of Alzheimer’s Clinical Trials

News

USC Receives Award to Improve Diversity and Efficiency of Alzheimer’s Clinical Trials

December 6, 2023

Read: Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease

Journal Article

Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease

October 13, 2023

Featured Experts: Doris Molina-Henry, PhD

Read: We Can Find Cancers with a Simple Blood Test

Perspective

We Can Find Cancers with a Simple Blood Test

September 19, 2023

Featured Experts: Dana Goldman, PhD

Read: 2023 Alzheimer’s Trial Recruitment Innovation Lab Fellowship Program — Application Open

News

2023 Alzheimer’s Trial Recruitment Innovation Lab Fellowship Program — Application Open

February 7, 2023

Read: The Inflation Reduction Act Is Already Killing Potential Cures

Perspective

The Inflation Reduction Act Is Already Killing Potential Cures

November 3, 2022

Featured Experts: Joseph Grogan, JD

Read: CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation

Evidence Base

CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation

October 21, 2022

Featured Experts: Joseph Grogan, JD

Read: Comments on AHRQ Analysis of Requirements for Coverage with Evidence Development

Comment Letter

Comments on AHRQ Analysis of Requirements for Coverage with Evidence Development

September 28, 2022

Featured Experts: Dana Goldman, PhD, William Padula, PhD, Joseph Grogan, JD, Barry Liden, JD

Read: Interdisciplinary Panel Offers Solutions to Improve Recruitment for Alzheimer’s Clinical Trials

News

Interdisciplinary Panel Offers Solutions to Improve Recruitment for Alzheimer’s Clinical Trials

August 16, 2022

Read: Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials

Journal Article

Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials

August 10, 2022

Featured Experts: Julie Zissimopoulos, PhD, Darius Lakdawalla, PhD, Desi Peneva, MS

Read: Lack of Diversity in Clinical Trials Costs Billions of Dollars. Incentives Can Spur Innovation

Perspective

Lack of Diversity in Clinical Trials Costs Billions of Dollars. Incentives Can Spur Innovation

August 5, 2022

Featured Experts: Dana Goldman, PhD

Read: Schaeffer Center Economic Modeling Contributes to National Academy Report on Diversity in Clinical Trials

News

Schaeffer Center Economic Modeling Contributes to National Academy Report on Diversity in Clinical Trials

May 17, 2022

Read: Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials

Journal Article

Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials

March 24, 2022

Featured Experts: Jakub Hlávka, PhD, Darius Lakdawalla, PhD

Read: Patient and Physician Perspectives On Engaging in Palliative and Healthcare Trials: A Qualitative Descriptive Study

Journal Article

Patient and Physician Perspectives On Engaging in Palliative and Healthcare Trials: A Qualitative Descriptive Study

October 14, 2021

Read: The Costs of Developing Treatments for Alzheimer’s Disease: A Retrospective Exploration

Journal Article

The Costs of Developing Treatments for Alzheimer’s Disease: A Retrospective Exploration

September 28, 2021

Featured Experts: Dana Goldman, PhD

Read: Latinos Are More Likely to Die From COVID-19, Underlining Racial and Ethnic Disparities in Outcomes

News

Latinos Are More Likely to Die From COVID-19, Underlining Racial and Ethnic Disparities in Outcomes

July 20, 2021